(Press-News.org) [Embargoed until 1 p.m. (ET) Sunday, Nov. 12]
WASHINGTON – Hormonal contraceptives taken by adolescents may influence development of the brain in a way that alters the recognition of risks, a new study in rats suggests.
Scientists at The Ohio State University are exploring how common synthetic hormones used for birth control affect the prefrontal cortex, an area of the brain that continues to develop throughout adolescence.
The researchers found that myelination, the formation of protective coating on axons projecting from the main body of brain cells, increased in rats given hormonal birth control compared to untreated rats, while the number of immune cells of the brain decreased. In behavior tests, the treated rats also showed signs of impulsivity.
“We start the rats on hormonal contraceptives as soon as they go through puberty and give them throughout adolescence, and then do behavioral tasks at the cusp of adulthood,” said Benedetta Leuner, co-senior author of the study and associate professor of psychology at Ohio State. “By the end of adolescence, impulsivity shouldn’t be as much of a thing, but that doesn’t seem to be the case – which, while highly speculative, suggests hormonal contraceptives might be stalling brain maturation.”
In addition, the study was the first to detect synthetic forms of these hormones in adolescent rats’ brain tissue.
“We now know that these synthetic hormones are actually getting to the brain, which is important. No one had ever shown that in adolescence,” Leuner said.
The study was presented in a poster session today (Nov. 12, 2023) at Neuroscience 2023, the annual meeting of the Society for Neuroscience.
An estimated 2 in 5 teenage girls in the United States have sexual intercourse between age 15 and 19. Among those using birth control, almost 5% use hormonal contraceptives – products that are also prescribed to treat acne and heavy periods.
Ohio State behavioral neuroscientists say it’s important to understand hormonal birth control’s effects on the developing brain so individuals can weigh the risks and benefits of their reproductive health choices.
The researchers gave a combination of synthetic estrogen and progesterone typically found in hormonal contraceptives to female rats from early to late adolescence and compared their behavior and brain tissue to untreated rats.
The study focused on myelination and immune cells called microglia because both have essential roles in prefrontal cortex development – and communication between cells in particular – that are controlled in part by natural hormones. Myelination facilitates signal transfer between cells, and microglia play a critical role in sculpting brain circuits.
Because synthetic hormones in contraceptives dampen ovaries’ production of natural estrogen and progesterone to prevent ovulation, the research team is looking at how those hormonal differences affect the brain while it is still developing.
“Synaptic development and myelination are occurring during this adolescent window and are sensitive to pubertal onset of hormones,” said co-senior author Kathryn Lenz, associate professor of psychology at Ohio State. “So we thought that disturbance of that normal pubertal hormonal activity could potentially shift the trajectory of some of those developmental processes.”
When it comes to nervous system communication, keeping it steady is key – too much or too little can lead to dysfunction that affects the mood and behavior. The finding that myelination increased and microglia decreased with hormonal contraception hints at disrupted communication, Lenz said – especially since other research teams have suggested that microglia regulate myelination.
“Shifts in either one or the other direction for both is really important to document and understand,” she said.
In behavior tests of threat appraisal, the rats given hormonal contraceptives were more likely than controls to remain in wide open elevated spaces and sample treats in unfamiliar settings – both considered risk-taking behavior.
A sensitive lab technique called liquid chromatography/mass spectrometry confirmed that the synthetic ethinyl estradiol and levonorgestrel given to the treated rats were present in brain tissue – a powerful piece of evidence that will guide future research.
“We don’t know if these effects are due to shutting down natural hormone production or if these synthetic hormones are acting directly in the brain,” Leuner said. “That’s a very big, open question.”
This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
First author Rachel Gilfarb, a graduate student in Leuner’s lab, presented the poster. Additional co-authors include Sanjana Ranade, Meredith Stewart, Abhishek Rajesh and Courtney Dye.
#
Contacts:
Benedetta Leuner, Leuner.1@osu.edu
Kathryn Lenz, Lenz.56@osu.edu
Written by Emily Caldwell, Caldwell.151@osu.edu; 614-292-8152
END
WASHINGTON – A surprising thing happened when researchers began exploring whether early-life stress compounds the effects of a childhood head injury on health and behavior later in life: In an animal study, stress changed the activation level of many more genes in the brain than were changed by a bump to the head.
It’s already known that head injuries are common in young kids, especially from falling, and can be linked to mood disorders and social difficulties that emerge later in life. Adverse childhood experiences are also very ...
Short-term increases in air pollution can cause problems for a lot of people, but especially to those with diagnosed or undiagnosed heart disease. But it’s not just a potential issue for pollution coming from cars and industrial processes.
New research from Intermountain Health in Salt Lake City shows that pollutants trapped in lower, colder layers of air in mountain-region communities present sometimes higher risk for this population, while wildfire smoke from often distant locales may also impact risk.
“We’re finding that air pollution is affecting ...
Low levels of Vitamin D have been shown to be associated with a higher risk of having a cardiac event, like a heart attack or stroke. For this reason, treatment by Vitamin D pills or injections are being investigated as a possible preventative method in these patients.
However, two new studies from Intermountain Health in Salt Lake City have found that current dosing recommendations are not helping patients achieve optimal Vitamin D levels, suggesting that trials looking into the effectiveness of Vitamin D treatment to prevent cardiac events were not using appropriately sufficient doses, leading to inaccurate results.
In their studies, Intermountain ...
The ventilation technique, also known as rescue breathing, commonly used during cardiopulmonary resuscitation (CPR) for people with cardiac arrest is often performed poorly by professional emergency responders, and this ineffective strategy is linked to significantly worse patient survival rates, according to a study supported by the National Institutes of Health. Ventilation involves administering breaths to a patient to provide life-sustaining oxygen and inflate the lungs when they stop breathing or during cardiac arrest, when the heart suddenly stops pumping blood. Among the nearly 2,000 ...
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found.
The oral anticoagulant medication, which helps to prevent dangerous blood clots by thinning the blood, reduced the risk of stroke and blood clotting by 37% and reduced fatal or disabling stroke by 49% in individuals with device-detected atrial fibrillation, also known as sub-clinical atrial ...
Familial hypercholesteremia (FH) is an inherited condition that affects about 1 in 250 people, and often shows no signs until they have a heart attack. For individuals with FH the lowering of “bad” cholesterol levels can’t be done by dietary or behavioral changes, the problem is in their genes, and targeted medications therapy is needed.
Now, new research from the Intermountain Health in Salt Lake City has found that genetic screening can identify these patients and make them candidates for treatment that could prevent heart attack, stroke, and death.
“Most of these patients already had tests that ...
New research from Intermountain Health in Salt Lake City finds that genetic screening is effective in identifying patients who have a heart condition known as cardiomyopathy to improve their quality of life and reduce deaths.
By undergoing genetic screening to identity those with the potentially-fatal heart condition, clinicians can more closely monitor them and use medical interventions, when necessary, that could improve the quality of these patients’ lives, and potentially save them, researchers say in a new study of more than 30,000 heart patients.
“Our findings show that we’re ...
SAN DIEGO, CA, NOVEMBER 12, 2023 — A recent study from Hospital for Special Surgery (HSS) and others has found a correlation between obesity and more severe disease flare symptoms that negatively affect quality of life in patients with early rheumatoid arthritis (RA), a systemic, autoimmune, inflammatory disorder affecting multiple joints in the body. The study will be presented at ACR Convergence 2023, the annual meeting of the American College of Rheumatology.
RA is usually treated with a combination of medications to relieve swelling and pain while regulating the immune ...
About The Study: Self-monitoring and physician-guided titration of antihypertensive medications was associated with lower blood pressure during the first nine months postpartum than usual postnatal outpatient care in this randomized clinical trial involving 220 participants in the United Kingdom.
Authors: Paul Leeson, Ph.D., of the University of Oxford in Oxford, United Kingdom, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.21523)
Editor’s ...
· High blood pressure is the leading cause of morbidity and mortality
· Losing one teaspoon of salt a day results in systolic blood pressure decline comparable to effect achieved with drugs
· First study to show people already on blood pressure medication could further lower their blood pressure by reducing sodium
Chicago --- Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, reports a new study from Northwestern Medicine, Vanderbilt University Medical Center and the University of Alabama at Birmingham.
“In the study, ...